← Leaderboards
Diane Ignar
Neuro10-9 Pharma, Inc.
$223,671
Attributed
$223,671
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$223,671 · 1
By mechanism
R43$223,671 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Antibody Formation”
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,353,846
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Lynn Briscoe · Leidos Biomedical Research, Inc.$13,229,918
- Norbert Pardi · University Of Pennsylvania$6,080,602
Research focus
Antibody FormationAntibody ResponseAqueousBaseBehavioralBiological AvailabilityBiological PreservationBirthBloodBlood - Brain Barrier AnatomyBoneBrainBrain ParenchymaCationsCessation Of LifeCharacteristicsChildhoodComplexCopolymerCore FacilityCost EffectivenessCytotoxicityDisease ModelAlpha Particles